Related Experiment Videos
Beta-thalassemia/haemoglobin E disease in Vietnam
C K Nguyen1, T T Le, B T Duong
1Institute for Protection of Children's Health, Hanoi, Vietnam.
Journal of Tropical Pediatrics
|February 1, 1990
Summary
Beta-thalassemia/hemoglobin E (HbE) in Vietnam presents severe anemia and enlarged spleens, similar to thalassemia major. This blood disorder significantly impacts red blood cell health and lifespan.
Area of Science:
- Hematology
- Genetics
- Clinical Medicine
Background:
- Beta-thalassemia/hemoglobin E (HbE) is a significant inherited blood disorder.
- Understanding its clinical and hematological profile is crucial for patient management.
Purpose of the Study:
- To describe the clinical and hematological characteristics of beta-thalassemia/HbE patients in Vietnam.
- To correlate specific genotypes with observed phenotypes.
Main Methods:
- Clinical assessment of 75 patients with beta-thalassemia/HbE.
- Hematological analysis including hemoglobin levels, red blood cell indices, and morphology.
- Erythrocyte osmotic fragility and lifespan assessment.
Main Results:
- Patients exhibited severe anemia (Hb 5.0 +/- 1.6 g/dl) and consistent splenomegaly.
- Red blood cells showed hypochromicity, microcytosis, and various morphological abnormalities.
- Erythrocytic lifespan was shortened (7-15 days), with splenic destruction in 63% of cases.
- Hemoglobin F (HbF) and Hemoglobin E (HbE) levels varied significantly between beta(+)-thalassemia/HbE and beta(0)-thalassemia/HbE genotypes.
Conclusions:
- Beta-thalassemia/HbE in Vietnam mirrors thalassemia major clinically.
- The study highlights the severe hematological impact and shortened red blood cell survival.
- Genotype-phenotype correlations are evident in HbF, HbE, and HbA1 levels.